万基遗传(MYGN)
搜索文档
Myriad(MYGN) - 2022 Q2 - Earnings Call Transcript
2022-08-07 13:18
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Foster Harris - IR Paul Diaz - CEO, President & Director Nicole Lambert - COO Bryan Riggsbee - EVP, CFO & Treasurer Conference Call Participants Kyle Boucher - Cowen and Company Jack Meehan - Nephron Research Operator Greetings, and welcome to the Myriad Genetics Second Quarter 2022 Financial Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded to ...
Myriad(MYGN) - 2022 Q1 - Earnings Call Transcript
2022-05-06 11:05
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Nathan Smith - Senior Vice President, Investor Relations Paul Diaz - President & Chief Executive Officer Bryan Riggsbee - Chief Financial Officer Nicole Lambert - Chief Operating Officer Conference Call Participants Jack Meehan - Nephron Research Kyle Boucher - Cowen Operator Greetings and welcome to the Myriad Genetics First Quarter 2022 Financial Earnings Call. During the presentation, all part ...
Myriad(MYGN) - 2021 Q4 - Earnings Call Transcript
2022-02-25 12:08
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Nathan Smith - Senior Vice President of Investor Relations & Treasury Paul Diaz - President & Chief Executive Officer Nicole Lambert - Chief Operating Officer Bryan Riggsbee - Executive Vice President & Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Sung Ji Nam - BTIG Rachel Olson - JPMorgan Operator Greetings and welcome to the Myriad Genetics Fourth Qu ...
Myriad(MYGN) - 2021 Q4 - Annual Report
2022-02-25 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________ FORM 10-K _______________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | |------------------------------------------------------------ ...